GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Kits Elisa; taq POLYMERASE

Search in Google:

google

Share this page:
share on twitter rss feedsfacebookgoogle gentaur



Quick order!
Enter catalog number :


Gentaur; yes we can

Related products :

Catalog number Product name Quantity
30-904 COIL is an integral component of Cajal bodies (also called coiled bodies). Cajal bodies are nuclear suborganelles of varying number and composition that are involved in the post-transcriptional modifi 0.05 mg
0021000500 METHYL-ISO-BUTYL KETONE 99 percent FOR SYNTHESIS, CAS: 108-10-1 5x500ML
0021002500 METHYL-ISO-BUTYL KETONE 99 percent FOR SYNTHESIS, CAS: 108-10-1 2x2,5LTR
002100200K METHYL-ISO-BUTYL KETONE 99 percent FOR SYNTHESIS, CAS: 108-10-1 200LTR
002100025K METHYL-ISO-BUTYL KETONE 99 percent FOR SYNTHESIS, CAS: 108-10-1 25LTR
0057500500 2-ACETYLTHIOPHENE 98 percent FOR SYNTHESIS (Methyl-2-Thienyl ketone), CAS: 88-15-3 500ML
0057500100 2-ACETYLTHIOPHENE 98 percent FOR SYNTHESIS (Methyl-2-Thienyl ketone), CAS: 88-15-3 3x100ML
orb82331 C. trachomatis D Elem. Bodies protein Chlamydia trachomatis D (UW-3_Cx Strain) Elementary Bodies is an infectious disease antigen_toxin. For research use only. 1 ml
29-213 SMN1 localizes to both the cytoplasm and the nucleus. Within the nucleus, the protein localizes to subnuclear bodies called gems which are found near coiled bodies containing high concentrations of sm 0.05 mg
30-937 ACSBG2 belongs to the ATP-dependent AMP-binding enzyme family, bubblegum subfamily.ACSBG2 mediates activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta- 0.05 mg
26-833 ACSBG2 belongs to the ATP-dependent AMP-binding enzyme family, bubblegum subfamily.ACSBG2 mediates activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta- 0.05 mg
20-272-191022 Basal Bodies of Cillia - Mouse monoclonal [LhS28] to Basal Bodies of Cillia Monoclonal 0.1 mg
EKBD-100 EnzyChrom™ Ketone Body Assay Kit, Quantitative determination of ketone body (acetoacetate and 3-hydroxybutyrate) in serum, plasma, urine etc at 340 nm 100Tests
30-956 Autophagy is the major intracellular degradation system delivering cytoplasmic components to lysosomes, and it accounts for degradation of most long-lived proteins and some organelles. Cytoplasmic con 0.05 mg
30-957 Autophagy is the major intracellular degradation system delivering cytoplasmic components to lysosomes, and it accounts for degradation of most long-lived proteins and some organelles. Cytoplasmic con 0.05 mg
EKBD-100 EnzyChrom™ Ketone Body Assay Kit, Quantitative determination of ketone body (acetoacetate and 3-hydroxybutyrate) in serum, plasma, urine etc at 340 nm. Procedure 30 min. Kit size 100 tests. Detectio 100tests
19437-26-4 Di_2_pyridyl ketone = Bis_(2_pyridyl)_keto Di_2_pyridyl ketone 1g
27-171 ERLIN2 plays an important role in the early steps of the endoplasmic reticulum-associated degradation (ERAD) pathway. It is involved in ITPR1 degradation by the ERAD pathway. 0.05 mg
31-050 MDM4 inhibits p53- and p73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. It inhibits degradation of MDM2. It can reverse MDM2-targeted degradation of p53 w 0.05 mg
31-051 MDM4 inhibits p53- and p73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. inhibits degradation of MDM2. It can reverse MDM2-targeted degradation of p53 whil 0.1 mg
5471-51-2 Raspberry ketone synthetic Raspberry Ketone synt 1g
5471-51-2 Raspberry ketone natural Raspberry ketone natur 1g
1453-52-7 dicyclopropyl ketone oxime dicyclopropyl ketone oxi 1g
38963-94-9 Raspberry Ketone _-D-Glucoside Raspberry Ketone _-D- 1g
GTX14373 Basal Bodies of Cillia 100 µg

Pathways :

WP101: Synthesis and Degradation of Ketone Bodies
WP1015: Synthesis and Degradation of Ketone Bodies
WP1134: Synthesis and Degradation of Ketone Bodies
WP1706: Synthesis and degradation of ketone bodies
WP2316: PPAR signaling pathway
WP311: Synthesis and Degradation of Ketone Bodies
WP333: Synthesis and Degradation of Ketone Bodies
WP349: Synthesis and Degradation of Ketone Bodies
WP427: Synthesis and Degradation of Ketone Bodies
WP543: Synthesis and Degradation of Ketone Bodies
WP784: Synthesis and Degradation of Ketone Bodies
WP898: Synthesis and Degradation of Ketone Bodies
WP1013: Triacylglyceride Synthesis
WP1034: Acetylcholine Synthesis
WP1079: Proteasome Degradation
WP1090: Eicosanoid Synthesis
WP1111: Prostaglandin Synthesis and Regulation
WP1118: Biogenic Amine Synthesis
WP1132: Triacylglyceride Synthesis
WP1196: Proteasome Degradation
WP1240: Proteasome Degradation
WP125: Biogenic Amine Synthesis
WP1318: Eicosanoid Synthesis
WP1347: Triacylglyceride Synthesis
WP1451: Valine, leucine and isoleucine degradation

Related Genes :
[DOA1 UFD3 ZZZ4 YKL213C] Protein DOA1 (Degradation of alpha protein 1) (Ubiquitin fusion degradation protein 3)
[CYB At1g57620 T8L23.9] Transmembrane emp24 domain-containing protein p24delta4 (Protein CYTOPLASMIC BODIES) (p24 family protein delta1b) (p24delta1b) (p24 family protein delta4) (p24delta4)
[Hmgcl] Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)
[Hmgcl] Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)
[HMGCL] Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)
[mbt CG18582] Serine/threonine-protein kinase PAK mbt (EC 2.7.11.1) (Protein mushroom bodies tiny) (p21-activated kinase-related protein)
[RREB1 FINB] Ras-responsive element-binding protein 1 (RREB-1) (Finger protein in nuclear bodies) (Raf-responsive zinc finger protein LZ321) (Zinc finger motif enhancer-binding protein 1) (Zep-1)
[Oamb oa1 CG3856] Octopamine receptor Oamb (Octopamine receptor in mushroom bodies)
[FAP] Prolyl endopeptidase FAP (EC 3.4.21.26) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) (Z-Pro-prolinal insensitive peptidase) (ZIP) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)]
[FAP] Prolyl endopeptidase FAP (EC 3.4.21.26) (170 kDa melanoma membrane-bound gelatinase) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)]
[Fap] Prolyl endopeptidase FAP (EC 3.4.21.26) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)]
[] Genome polyprotein [Cleaved into: Protein VP0 (VP4-VP2); Protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Protein VP1-2A (VP1-pX); Capsid protein VP1 (P1D) (Virion protein 1); Assembly signal 2A (pX); Protein 2BC; Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3ABCD (P3); Protein 3ABC; Protein 3AB; Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD; Protease 3C (P3C) (EC 3.4.22.28) (Picornain 3C); RNA-directed RNA polymerase 3D-POL (P3D-POL) (EC 2.7.7.48)]
[UFD1 UFD1L] Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1)
[ACAT1 ACAT MAT] Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (T2)
[GLYI-11 GLX-I Os08g0191700 LOC_Os08g09250 OSJNBa0056O06.9-1] Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Allergen Glb33) (Glyoxalase I) (Glx I) (Glyoxylase I 11) (OsGLYI-11) (OsGLYI11) (Ketone-aldehyde mutase) (Methylglyoxalase) (PP33) (S-D-lactoylglutathione methylglyoxal lyase) (allergen Ory s Glyoxalase I)
[gloA b1651 JW1643] Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)
[glo1 SPBC12C2.12c SPBC21D10.03c] Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)
[GLO1] Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)
[Glo1] Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)
[Glo1] Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)
[GLXI] Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (GmGlyoxI) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)
[OXCT1 OXCT SCOT] Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s)
[PML MYL PP8675 RNF71 TRIM19] Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19)
[OXCT1 OXCT SCOT] Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s)
[Oxct1 Oxct Scot] Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s)
[VID24 GID4 YBR105C YBR0834] Vacuolar import and degradation protein 24 (Glucose-induced degradation protein 4)
[Ufd1 Ufd1l] Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1 homolog) (UB fusion protein 1)
[AKT2] RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta)
[GLO1 YML004C YM9571.15C] Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)
[HMGCL] Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)

Bibliography :
[30856112] Preliminary Report on the Feasibility and Efficacy of the Modified Atkins Diet for Treatment of Mild Cognitive Impairment and Early Alzheimer's Disease.
[30826371] Metabolomics profiling and pathway analysis of human plasma and urine reveal further insights into the multifactorial nature of coronary artery disease.
[30823582] Transcriptomic Analysis for and Rice Varieties under Aluminum Toxicity.
[30822172] Metabolism of the failing heart and the impact of SGLT2 inhibitors.
[30799594] A Rare Cause of Life-Threatening Ketoacidosis: Novel Compound Heterozygous Mutations Causing Succinyl-CoA:3-Ketoacid CoA Transferase Deficiency.
[30793304] The potential contribution of impaired brain glucose metabolism to congenital Zika syndrome.
[30785686] [Formation in the phylogenesis of three pulls of cells with expressed different absorption and metabolism of fatty acids. Insulin and medium chains fatty acids.]
[30779128] Prospective Serum Metabolomic Profiling of Lethal Prostate Cancer.
[30764676] Impact of dietary lipoic acid supplementation on liver mitochondrial bioenergetics and oxidative status on normally fed Wistar rats.
[30730834] Molecular effects of dietary fatty acids on brain insulin action and mitochondrial function.